Literature DB >> 9652439

Enteroaggregative Escherichia coli as a potential cause of diarrheal disease in adults infected with human immunodeficiency virus.

C A Wanke1, H Mayer, R Weber, R Zbinden, D A Watson, D Acheson.   

Abstract

Stools of 68 human immunodeficiency virus (HIV)-infected adults with diarrhea and 60 without diarrhea were examined for enteroaggregative Escherichia coli (EAggEc) by HeLa cell adherence assay. EAggEc were present in stools of 30 patients with and 18 without diarrhea (P = .05). CD4 cell counts of patients with EAggEc and diarrhea were significantly lower than those of patients with EAggEc without diarrhea (P = .02). There was no difference in the mean duration of diarrheal symptoms or in the number of stools per day between patients with EAggEc and those without. None of the EAggEc strains were positive by polymerase chain reaction for adherence fimbria, but 11 strains were positive for EAggEc heat-stable toxin EAST/1. Of the EAggEc strains, 51% were resistant to trimethoprim-sulfamethoxazole and 65% were resistant to ampicillin. EAggEc may be a pathogen in HIV-infected patients with diarrhea; HIV-infected patients with EAggEc appear to be more symptomatic when HIV disease is more advanced.

Entities:  

Mesh:

Year:  1998        PMID: 9652439     DOI: 10.1086/515595

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

1.  AIDS diarrhea and antiretroviral drug concentrations: a matched-pair cohort study in Port au Prince, Haiti.

Authors:  Rebecca Dillingham; Paul Leger; Carole-Anne Beauharnais; Erica Miller; Angela Kashuba; Steven Jennings; Kathryn Dupnik; Amidou Samie; Etna Eyma; Richard Guerrant; Jean Pape; Daniel Fitzgerald
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

Review 2.  HIV1 and the gut in the era of highly active antiretroviral therapy.

Authors:  Esteban C Nannini; Pablo C Okhuysen
Journal:  Curr Gastroenterol Rep       Date:  2002-10

3.  New adhesin of enteroaggregative Escherichia coli related to the Afa/Dr/AAF family.

Authors:  Nadia Boisen; Carsten Struve; Flemming Scheutz; Karen A Krogfelt; James P Nataro
Journal:  Infect Immun       Date:  2008-04-28       Impact factor: 3.441

Review 4.  Animal models of enteroaggregative Escherichia coli infection.

Authors:  Casandra W Philipson; Josep Bassaganya-Riera; Raquel Hontecillas
Journal:  Gut Microbes       Date:  2013-05-02

5.  Identification of enteropathogenic Escherichia coli in simian immunodeficiency virus-infected infant and adult rhesus macaques.

Authors:  K G Mansfield; K C Lin; J Newman; D Schauer; J MacKey; A A Lackner; A Carville
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

Review 6.  Shiga toxin-producing Escherichia coli O104:H4: an emerging pathogen with enhanced virulence.

Authors:  Dakshina M Jandhyala; Vijay Vanguri; Erik J Boll; Yushuan Lai; Beth A McCormick; John M Leong
Journal:  Infect Dis Clin North Am       Date:  2013-07-24       Impact factor: 5.982

7.  Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen.

Authors:  P Kaur; A Chakraborti; A Asea
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-03-11

8.  Virulent bacteriophages can target O104:H4 enteroaggregative Escherichia coli in the mouse intestine.

Authors:  Damien Maura; Matthieu Galtier; Chantal Le Bouguénec; Laurent Debarbieux
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

9.  The presence of the pAA plasmid in the German O104:H4 Shiga toxin type 2a (Stx2a)-producing enteroaggregative Escherichia coli strain promotes the translocation of Stx2a across an epithelial cell monolayer.

Authors:  Nadia Boisen; Anne-Marie Hansen; Angela R Melton-Celsa; Tonia Zangari; Ninell Pollas Mortensen; James B Kaper; Alison D O'Brien; James P Nataro
Journal:  J Infect Dis       Date:  2014-07-18       Impact factor: 5.226

10.  Complete genome sequence and comparative metabolic profiling of the prototypical enteroaggregative Escherichia coli strain 042.

Authors:  Roy R Chaudhuri; Mohammed Sebaihia; Jon L Hobman; Mark A Webber; Denisse L Leyton; Martin D Goldberg; Adam F Cunningham; Anthony Scott-Tucker; Paul R Ferguson; Christopher M Thomas; Gad Frankel; Christoph M Tang; Edward G Dudley; Ian S Roberts; David A Rasko; Mark J Pallen; Julian Parkhill; James P Nataro; Nicholas R Thomson; Ian R Henderson
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.